Market research
KHRN.V Khiron Life Sciences Corp
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9M
- P/E ratio
- Not available
- Analyst target
- 0.1
- Dividend yield
- Not available
- Beta
- 2.64
Community
Investor discussion
1 comment
Sign in to join the KHRN.V discussion.
5 years, 5 months ago
Khiron Life Sciences Corp is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.5.
Khiron Life Sciences Corp's total revenue sank by 30.5% to $2M since the same quarter in the previous year.
Its net income has increased by 36.8% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.8% to $-5M since the same quarter in the previous year.
Based on the above factors, Khiron Life Sciences Corp gets an overall score of 3/5.